CTOs on the Move

Gereonics

www.gereonics.com

 
Gereonics Inc. is a Solana Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.gereonics.com
  • 244 La Barranca Dr
    Solana Beach, CA USA 92075
  • Phone: 760.612.3554

Executives

Name Title Contact Details

Similar Companies

Eagle Laboratories

Eagle Laboratories is a Rancho Cucamonga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedPricer

Medpricer empowers industry-leading sourcing teams To help you with the continued pressure to optimize healthcare costs, our expert team and best-in-class technology triples your internal sourcing capacity and helps you cut purchased services expenses by an average of 24% without costing you a dime. You lead – We empower You retain the control of your goals and decisions. With the Medpricer methodology and $2.7 billion of Purchased Services sourcing experience, you extend your sourcing capability upfront and establish a best-in-class infrastructure to drive ongoing success in the future. Process more than you ever imagined We discover and optimize every Purchased Service category in your organization. Built on a time-tested methodology, our industry-leading custom contracting platform helps organizations consolidate spend data and manage negotiations more. Your GPO can`t help you like we can We give your team the expertise and flexibility of a consultant with the scalability of a GPO. Access our vendor-paid, independent custom contracting system to secure the right terms at the right price for all of your 400+ Purchased Service categories.

Kryosphere

Kryosphere is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RxSight

RxSight® is a privately-held corporation headquartered in Aliso Viejo, California that has commercialized the world`s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.